Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.45 |
| ▸ | PPARG | P37231 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | PPARA | Q07869 | 7/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16842693 | 1.00 | TSHR (0.48) | TSHRLMNANFKB1PMP22ALOX5 | |
| SCHEMBL10994781 | 0.88 | TSHR (0.40) | TSHRLMNANFKB1PMP22ALOX5 | |
| SCHEMBL27990496 | 0.83 | TSHR (0.52) | TSHRLMNANFKB1PMP22ALOX5 | |
| SCHEMBL23454432 | 0.83 | — | — | |
| SCHEMBL580439 | 0.79 | ALDH1A1 (0.63) | TSHRLMNANFKB1PMP22ALOX5 | |
| Chaulmoogric Acid SCHEMBL560850 | 0.79 | ALDH1A1 (0.63) | TSHRLMNANFKB1PMP22ALOX5 | |
| SCHEMBL4558351 | 0.79 | ALDH1A1 (0.63) | TSHRLMNANFKB1PMP22ALOX5 | |
| SCHEMBL10994499 | 0.79 | ALOX5 (0.39) | TSHRLMNANFKB1PMP22ALOX5 | |
| Chaulmoogric Acid SCHEMBL560849 | 0.79 | ALDH1A1 (0.63) | TSHRLMNANFKB1PMP22ALOX5 | |
| SCHEMBL2491883 | 0.79 | ALDH1A1 (0.63) | TSHRLMNANFKB1PMP22ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150175519-A1 | AMPHIPHILIC CYCLOBUTENES AND CYCLOBUTANES | NUTECH VENTURES | 2015-06-25 | — | — | US | disclosed |
| US-20150175519-A1 | AMPHIPHILIC CYCLOBUTENES AND CYCLOBUTANES | NUTECH VENTURES | 2015-06-25 | — | — | US | disclosed |
| EP-2855415-A1 | AMPHIPHILIC CYCLOBUTENES AND CYCLOBUTANES | Nutech Ventures, Inc. (US) | 2015-04-08 | — | — | EP | disclosed |
| WO-2013181155-A1 | AMPHIPHILIC CYCLOBUTENES AND CYCLOBUTANES | NUTECH VENTURES (US) | 2013-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175519-A1 | AMPHIPHILIC CYCLOBUTENES AND CYCLOBUTANES | FNTB, ABCB4, ALG1 | TSHR 3151/4885LMNA 1736/4885NFKB1 747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.